than I was doing at Christmas,” the former Nebraska senator and University of Florida president said.
But the journey has been anything but simple. Sasse is participating in a clinical trial for daraxonrasib, a targeted therapy aimed at slowing pancreatic cancer by blocking the mutant proteins that drive the disease in most patients.
